Metoprolol XR in Heart Failure With Normal Ejection Fraction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT03882710

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03882710
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03882710. Randomized; double masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metoprolol XR in Heart Failure With Normal Ejection Fraction
Acronym
HFNEF
Condition
Diastolic Heart Failure
Intervention (Drug)
Metoprolol XR
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh (class: other)

Record details

Record id
cardio:ct-nct03882710
Content hash
412f59f2b6346db2ad9796cfc7752516c7c56a9eb17f409acbb0d26b9dc8f6a4